Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C1-INH for HAE Prodromal Symptoms
NCT01151735Phase 4Withdrawn
- Sponsor
- The Pennsylvania State University
- Start
- Jul 2010
- Primary completion
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by The Pennsylvania State University. Planned start Jul 2010; status: withdrawn.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT01151735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01151735.